Primary refractoriness to platelet transfusion caused by Naka antibody alone

Vox Sanguinis

Volumn 81, Issue 1, 2001, Pages 42-44

  Fujino, H ^a   Ohta, K ^a   Taniue, A ^b   Nagao, N ^b   Hino, M ^a   Yamane, T ^a   Koh, K R ^a   Takeoka, Y ^a   Hirose, A ^a   Aoyama, Y ^a   Nakamae, H ^a   Terada, Y ^a   Takubo, T ^a   Tatsumi, N ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SUWA RED CROSS HOSPITAL   (Japan)

Author keywords

Naka; Platelet transfusion; Platelet specific antibodies; Transfusion refractoriness

Indexed keywords

ANTIBODY; CD36 ANTIBODY; CD36 ANTIGEN; CISPLATIN; ETOPOSIDE; HLA ANTIBODY; IFOSFAMIDE; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELL SELECTION; CLINICAL FEATURE; FLOW CYTOMETRY; HLA TYPING; HUMAN; MALE; PREGNANCY; PRIORITY JOURNAL; SCREENING; SEMINOMA; TESTIS TUMOR; THROMBOCYTE TRANSFUSION;

ADULT; ANTIGENS, CD36; ANTIGENS, HUMAN PLATELET; BLOOD PLATELETS; HUMANS; ISOANTIBODIES; MALE; PLATELET COUNT; PLATELET TRANSFUSION; TESTICULAR NEOPLASMS;

EID: 0035412594     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2001.00048.x     Document Type: Article

References (9)

1. Novotny VMJ: Prevention and management of platelet transfusion refractoriness. Vox Sang 1999; 76:1-13
2. a, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 1989; 57:213-217
3. Bokemeyer C, Kollmannsberer C, Meisner C, Harstick A, Beyer J, Metzner B, Hartmann JT, Schumoll HJ, Einhorn L, Kanz L, Nichols C: First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients and matched-pair analysis. J Clin Oncol 1999; 17:3450-3456
4. Margolin K, Doroshow HJ, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M: Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol 1996; 14:2631-2637
5. Yamane T, Hino M, Ohta K, Nakao T, Nakamae H, Yamamura R, Takubo T, Tatsumi N: Peripheral blood stem cell transplantation for non-Hodgkin's lymphoma in complete remission. Osaka City Med J 1998; 44:219-223
6. Araki N, Shibata Y, Inaba H, Nose Y, Sakata N, Ito K: Anti-HLA antibody screening with extracted platelet HLA antigens by the mixed passive hemagglutination method. Vox Sang 1995; 69:222-230
7. Shibata Y, Juji T, Nishizawa Y, Sakamoto H, Ozawa N: Detection of platelet antibodies by a newly developed mixed aggulation with platelets. Vox Sang 1981; 41:25-31
8. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K: Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83:392-397
9. a, on platelet membrane glycoprotein IV. Blood 1990; 75:684-687